Tomita Minoru, Waring George O
From the Shinagawa LASIK Center (Tomita) Tokyo, Japan; the Department of Ophthalmology (Tomita), Wenzhou Medical College, Wenzhou, China; the Storm Eye Institute (Waring), Medical University of South Carolina and Magill Vision Center (Waring), Charleston, South Carolina, USA.
From the Shinagawa LASIK Center (Tomita) Tokyo, Japan; the Department of Ophthalmology (Tomita), Wenzhou Medical College, Wenzhou, China; the Storm Eye Institute (Waring), Medical University of South Carolina and Magill Vision Center (Waring), Charleston, South Carolina, USA.
J Cataract Refract Surg. 2015 Jan;41(1):152-61. doi: 10.1016/j.jcrs.2014.05.037.
To compare by age the safety, efficacy, and patient satisfaction after simultaneous laser in situ keratomileusis (LASIK) and small-aperture corneal inlay implantation (Kamra) for hyperopic presbyopia.
Shinagawa LASIK Center, Tokyo, Japan.
Retrospective comparative cohort study.
Simultaneous LASIK and small-aperture corneal inlay implantation were performed in the nondominant eye of hyperopic presbyopic patients with astigmatism. Patients were divided into groups by age as follows: Group 1 (40 to 49 years), Group 2 (50 to 59 years), and Group 3 (60 to 65 years). The uncorrected (UDVA) and corrected (CDVA) distance visual acuities, uncorrected near visual acuity (UNVA), and patient questionnaire results were compared.
The study evaluated 277 eyes of 277 patients. All groups achieved a mean UDVA of 20/20, with Group 1, Group 2, and Group 3 gaining 1 line, 2 lines, and 3 lines, respectively. The mean UNVA was J2 with 4 lines gained in Group 1 and J3 with 5 lines gained in Group 2 and Group 3. The mean CDVA and corrected near visual acuity remained the same as at baseline.
Simultaneous LASIK and small-aperture corneal inlay implantation for hyperopic presbyopia was a safe and effective treatment option. Although the outcomes were comparable between groups, Group 3 had the largest gain in UDVA and UNVA and the highest patient satisfaction, despite having the lowest reduction in dependence on reading glasses. Taking age into account might help achieve optimum postoperative outcomes and improved patient satisfaction.
Dr. Tomita is a consultant to Ziemer Ophthalmic Systems AG, Acufocus, Inc., and Schwind eye-tech-solutions GmbH and Co. KG. Dr. Waring is a consultant to Acufocus, Inc.
按年龄比较同时进行准分子原位角膜磨镶术（LASIK）和小切口角膜嵌体植入术（Kamra）治疗远视性老视后的安全性、有效性和患者满意度。
日本东京品川LASIK中心。
回顾性比较队列研究。
对有散光的远视性老视患者的非优势眼同时进行LASIK和小切口角膜嵌体植入术。患者按年龄分为以下几组：第1组（40至49岁）、第2组（50至59岁）和第3组（60至65岁）。比较未矫正远视力（UDVA）、矫正远视力（CDVA）、未矫正近视力（UNVA）以及患者问卷调查结果。
该研究评估了277例患者的277只眼。所有组的平均UDVA均达到20/20，第1组、第2组和第3组分别提高了1行、2行和3行。平均UNVA在第1组为J2且提高了4行，在第2组和第3组为J3且提高了5行。平均CDVA和矫正近视力与基线时相同。
同时进行LASIK和小切口角膜嵌体植入术治疗远视性老视是一种安全有效的治疗选择。尽管各组结果相当，但第3组的UDVA和UNVA提高幅度最大，患者满意度最高，尽管其对老花镜的依赖减少程度最低。考虑年龄因素可能有助于实现最佳术后效果并提高患者满意度。
富田医生是齐默眼科系统股份公司、Acufocus公司和施温德眼科技解决方案有限责任公司及两合公司的顾问。韦林医生是Acufocus公司的顾问。
Zotero 插件